Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.
about
Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Which Patients Will Benefit fr ...... of the Lantus Registry Study.
@en
type
label
Which Patients Will Benefit fr ...... of the Lantus Registry Study.
@en
prefLabel
Which Patients Will Benefit fr ...... of the Lantus Registry Study.
@en
P2093
P2860
P1433
P1476
Which Patients Will Benefit fr ...... s of the Lantus Registry Study
@en
P2093
Lantus Registry Study Group
Wenying Yang
Xiaoyan Xing
Xuelian Zhang
Ying Shuai
P2860
P2888
P304
P356
10.1007/S13300-017-0284-1
P50
P577
2017-06-16T00:00:00Z
P6179
1086042905